Search Results - David Fandrei

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M by David Fandrei, Tony Huynh, Marie Sébert, Lorea Aguinaga, Valeria Bisio, Rathana Kim, Emmanuelle Clappier, Marion Espéli, Karl Balabanian, Hélène Moins-Teisserenc, Antoine Toubert, Nicolas Dulphy, Pierre Fenaux, Lionel Adès, Lin-Pierre Zhao

    Published in Blood Cancer Journal (2023-12-01)
    Get full text
    Article


  2. 2

    Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma by Patrick Born, David Fandrei, Song Yau Wang, Carmen Perez‐Fernandez, Luise Fischer, Jule Ussmann, Enrica Bach, Sandra Hoffmann, Klaus H. Metzeler, Marco Herling, Carmen Herling, Madlen Jentzsch, Andreas Boldt, Sabine Seiffert, Ronny Baber, Heike Weidner, Georg‐Nikolaus Franke, Timm Denecke, Osama Sabri, Uwe Platzbecker, Vladan Vucinic, Hans Jonas Meyer, Lars Kurch, Maximilian Merz

    Published in HemaSphere (2025-06-01)
    Get full text
    Article


  3. 3

    Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study by Maximilian Merz, Anca‐Maria Albici, Bastian vonTresckow, Kristin Rathje, Roland Fenk, Tobias Holderried, Fabian Müller, Natalia Tovar, Aina Oliver‐Cáldes, Vladan Vucinic, Soraya Kharboutli, Ben‐Niklas Bärmann, Francis Ayuk, Uwe Platzbecker, Friedrich Stölzel, Nathalie Schub, Friederike Schmitz, David Fandrei, Patrick Born, Cyrus Khandanpour, Christine Hanoun, Keven Hörster, Marcel Teichert, Barbara Jeker, Michele Hoffmann, Nicolaus Kröger, Carlos Fernández de Larrea, Thomas Pabst, Nico Gagelmann

    Published in HemaSphere (2025-01-01)
    Get full text
    Article


  4. 4

    Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy by Maximilian Merz, Danai Dima, Hamza Hashmi, Nausheen Ahmed, Friedrich Stölzel, Tobias A. W. Holderried, Roland Fenk, Fabian Müller, Natalia Tovar, Aina Oliver-Cáldes, Kristin Rathje, James A. Davis, David Fandrei, Vladan Vucinic, Soraya Kharboutli, Ben-Niklas Baermann, Francis Ayuk, Uwe Platzbecker, Anca-Maria Albici, Nathalie Schub, Friederike Schmitz, Leyla Shune, Jack Khouri, Faiz Anwer, Shahzad Raza, Joseph McGuirk, Zahra Mahmoudjafari, Kimberly Green, Cyrus Khandanpour, Marcel Teichert, Barbara Jeker, Michele Hoffmann, Nicolaus Kröger, Bastian von Tresckow, Carlos Fernández de Larrea, Thomas Pabst, Al-Ola Abdallah, Nico Gagelmann

    Published in Blood Cancer Journal (2024-12-01)
    Get full text
    Article


  5. 5

    Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies by Ulrike Weirauch, Markus Kreuz, Colin Birkenbihl, Miriam Alb, Maria Quaranta, Laurence Calzone, Sophia Orozco-Ruiz, Stefanie Binder, Luise Fischer, Solène Clavreul, Morine Maguri, Maximilian Ferle, Michael Rade, Guillaume Azarias, Jay R. Hydren, Jakub Jamarik, Daniel Schwarz, Zsolt Sebestyen, Jurgen Kuball, Georg Popp, Chloé Antoine, Manon Knockaert, Clara T. Schoeder, David Fandrei, Carmen Sanges, Vaclovas Radvilas, Nico Gagelmann, Markus Rückert, Olaf Penack, Stephan Fricke, Andreas Schmidt, Carol Ward, Carl Steinbeisser, Jean-Marc Van Gyseghem, Anna Niarakis, Laurent Garderet, Michael Hudecek, Thomas Neumuth, Uwe Platzbecker, Ulrike Köhl, Regina Demlova, Andreas Kremer, Stefan Franke, Holger Fröhlich, Maximilian Merz, Kristin Reiche, On behalf of the CERTAINTY Consortium

    Published in npj Digital Medicine (2025-08-01)
    Get full text
    Article


Search Tools: